Article
Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions.
European journal of pharmacology - 5 Dec 2012
Hammons Andrea L, Summers Carolyn M, Jochems Jeanine, Arora Jasbir S, Zhang Suhong, Blair Ian A, Whitehead Alexander S
Abstract excerpt
Elevated homocysteine is a risk marker for several major human pathologies. Emerging evidence suggests that perturbations of folate/homocysteine metabolism can directly modify production of inflammatory mediators. Pemetrexed acts by inhibiting thymidylate synthetase (TYMS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT). EA.hy 926 cells grown under low ("Lo") and high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
